BERLIN, May 15, 2007 - In the first quarter 2007, the Berlin-based biotech company MOLOGEN has generated EBIT of -1.7 million EUR in the Consolidated Financial Statements prepared in line with IFRS. In the comparison period, EBIT was -0.8 million EUR. Sales of 0.2 million EUR remained at the level of last year. Net income amounted to -1.6 million EUR compared to -0.8 Million EUR in the first quarter 2006.
